Hicks Equity leads $7 mln round for Sight Sciences
Sight Sciences Inc has closed a $7 million Series B round led by Hicks Equity Partners. All Series A investors participated in the round including Scientific Health Development (Series A Co-Lead), Allegro Investment Fund, and various other institutional and angel investors. Menlo Park, California-based Sight Sciences is a commercial stage ophthalmic medical device company.
15 March 2016•3 mins read
